Home›People›Aaron Sandoski
Aaron Sandoski

Aaron Sandoski

Board director at Nanopath

DirectorRoles at 3 startups
Updated Nov 13, 2026·Latest SEC filing Nov 13, 2026·Suggest an edit

About Aaron Sandoski

Aaron Sandoski is a board director at Nanopath, which develops tests for women’s pelvic and gynecologic infections. He joined its board in 2022. At that time, he was a founding partner of Medtech Convergence Fund, a fund run by SV Health Investors.

Experience

This experience comes from official bios, from Aaron Sandoski's profile and from SEC filings. For roles taken from filings, the years are when the filings name Aaron Sandoski in the role, so the role may have started earlier or lasted longer.

Nanopath Inc Current
Board Director
2025 – Present · Cambridge, MA
Nanopath develops clinic-based molecular tests designed to return actionable infection results during one office visit.
Medtech Convergence Fund Current
Founding Partner
2020 – Present
Lexington Medical, Inc. Current
Investor/Board Member
2015 – Present · Bedford, MA
MassMEDIC Current
Board Member
2015 – Present
Podimetrics Current
Investor/Board Member
2013 – Present
Norwich Ventures Current
Co-founder & Managing Director
2004 – Present
SV Health Investors' Medtech Convergence Fund Current
founding partner
Alpheus Medical, Inc.
Director
2020 – 2022 · Chanhassen, MN
Develops an investigational drug and ultrasound therapy for people with glioblastoma.
Affera, Inc.
Investor/Board Member
2014 – 2022
Pelvalon (acquired by Laborie)
Investor/Board Member
2010 – 2021
Vaxess Technologies
Investor/Board Member
2013 – 2019
Daktari Diagnostics
Investor/Board Member
2009 – 2017
Intelligent BIo-Systems, Inc.- A Qiagen Company
Investor/Board Member
2009 – 2012
Rhythmia Medical, Inc.
Investor/Board Member
2007 – 2012
DEKA Research & Development
Business Development
2001 – 2002
Solspark
Director, Business Development
2000
Express Scripts/YourPharmacy
Manager, Marketing
1999 – 2000
McKinsey & Company
Associate
1996 – 1999

Key Colleagues at Startups

The people Aaron Sandoski works with at each company, as listed on that company's latest Form D.

Nanopath Inc · Form D, Nov 13, 2026
Amogha Tadimety
Amogha Tadimety
Co-Founder, Co-CEO, Board Director
Alison Burklund
Alison Burklund
Co-Founder, Co-CEO, Board Director
JC
Jeff Crowe
Board Director
Lexington Medical, Inc. · Form D, Apr 29, 2025
DR
LA
Leon Amariglio
President and director
DH
Doron Harlev
Director
DL
David Lang
Director
Alpheus Medical, Inc. · Form D, Nov 9, 2022
PT
Vijay Agarwal
Vijay Agarwal
Founder, President and CEO, director
TK
Terrance Kurtenbach
Executive officer
IE
Imran Eba
Chief Financial Officer and director
KV
Klaus Veitinger
Executive Chairman of the Board

Sources

  1. SECNanopath Inc Form D, filed Nov 13, 2026
  2. SECLexington Medical, Inc. Form D, filed Apr 29, 2025
  3. SECAlpheus Medical, Inc. Form D, filed Nov 9, 2022
  4. P2Nanopath Series A announcement